Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

DMTK

DermTech Inc

Nov 28 • 01:41PM ET

1.62

Dollar change +0.13
Percentage change 8.78	%

Healthcare • Diagnostics & Research • USA • NASD

Stock Detail • Compare Perf. • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-3.51	Insider Own	11.67%	Shs Outstand	30.30M	Perf Week	10.26%
Market Cap	55.50M	Forward P/E	-	EPS next Y	-2.13	Insider Trans	-1.13%	Shs Float	30.25M	Perf Month	37.36%
Income	-110.02M	PEG	-	EPS next Q	-0.60	Inst Own	20.90%	Short Float / Ratio	17.75% / 21.80	Perf Quarter	-30.14%
Sales	14.37M	P/S	3.86	EPS this Y	17.87%	Inst Trans	-25.36%	Short Interest	5.37M	Perf Half Y	-33.57%
Book/sh	2.13	P/B	0.76	EPS next Y	33.16%	ROA	-66.29%	Target Price	3.60	Perf Year	-32.75%
Cash/sh	1.99	P/C	0.81	EPS next 5Y	-	ROE	-96.49%	52W Range	1.12 - 6.44	Perf YTD	-8.43%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-87.83%	52W High	-74.83%	Beta	2.35
Dividend %	-	Quick Ratio	5.91	Sales past 5Y	39.75%	Gross Margin	-3.62%	52W Low	44.71%	ATR	0.13
Employees	279	Current Ratio	6.01	Sales Q/Q	9.57%	Oper. Margin	-785.65%	RSI (14)	59.00	Volatility	7.42% 9.96%
Optionable	Yes	Debt/Eq	0.76	EPS Q/Q	40.75%	Profit Margin	-765.84%	Rel Volume	1.42	Prev Close	1.49
Shortable	Yes	LT Debt/Eq	0.71	Earnings	Nov 02 AMC	Payout	-	Avg Volume	246.37K	Price	1.62
Recom	1.67	SMA20	10.82%	SMA50	12.46%	SMA200	-39.77%	Volume	231,432	Change	8.78%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-18-22	Resumed	Oppenheimer	Outperform	$48
Jun-14-22	Reiterated	BTIG Research	Buy	$38 → $19
Jan-07-22	Initiated	Stephens	Overweight	$26
Oct-15-21	Resumed	Cowen	Outperform	$50
May-03-21	Initiated	BTIG Research	Buy	$53
Jan-22-21	Initiated	Oppenheimer	Outperform	$53
Dec-14-20	Initiated	Craig Hallum	Buy	$23
Oct-30-20	Initiated	William Blair	Outperform
Dec-05-19	Initiated	Lake Street	Buy

Nov-08-23 03:34PM	DMTK STOCK NEWS: Shareholders With Large Losses Should Contact Robbins LLP for Information About Their Rights Against DermTech, Inc. (GlobeNewswire)
Nov-07-23 04:13PM	DermTech, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; December 15, 2023 deadline (GlobeNewswire) +10.96%
Nov-03-23 09:35AM	DermTech, Inc. (NASDAQ:DMTK) Q3 2023 Earnings Call Transcript (Insider Monkey) +5.71%
Nov-02-23 05:47PM	DermTech Inc (DMTK) Reports 10% Increase in Total Revenue for Q3 2023 (GuruFocus.com)
04:01PM	DermTech Reports Third-Quarter 2023 Financial Results (Business Wire)
09:32AM	Loading…
Oct-23-23 09:32AM	DMTK INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that DermTech, Inc. Investors with Substantial Losses Have Opportunity to Lead Case (GlobeNewswire) -6.87%
Oct-18-23 03:55PM	DermTech, Inc. investors: Please contact the Portnoy Law Firm to recover your losses; December 15, 2023 deadline (GlobeNewswire)
Oct-12-23 08:05AM	DermTech Announces Release Date for Third-Quarter 2023 Financial Results (Business Wire) -8.22%
Sep-21-23 04:05PM	DermTech Grants New CCO Mark Aguillard Inducement Award Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Sep-19-23 08:05AM	DermTech Announces Contracts With Highmark for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire)
Sep-13-23 05:55PM	Insider Sell: DermTech Inc CFO Kevin Sun Sells 9,616 Shares (GuruFocus.com)
Sep-11-23 08:05AM	DermTech Appoints Mark Aguillard as Chief Commercial Officer (Business Wire) +9.38%
Aug-31-23 09:40AM	Is DiaMedica Therapeutics (DMAC) Stock Outpacing Its Medical Peers This Year? (Zacks)
Aug-25-23 08:05AM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Aug-09-23 09:06AM	DermTech (NASDAQ:DMTK) Will Have To Spend Its Cash Wisely (Simply Wall St.)
05:35PM	Loading…
Aug-03-23 05:35PM	DermTech, Inc. (DMTK) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	DermTech Reports Second-Quarter 2023 Financial Results (Business Wire)
Jul-19-23 08:00AM	DermTech Announces Favorable Coverage Policy With Blues Plan in Michigan for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) +19.56%
Jul-17-23 08:00AM	DermTech Announces Release Date for Second-Quarter 2023 Financial Results (Business Wire) +5.38%
Jul-13-23 07:43AM	DermTech, Inc. (NASDAQ:DMTK) surges 21%; retail investors who own 59% shares profited along with institutions (Simply Wall St.)
Jul-12-23 08:00AM	DermTech Adds Approximately 7 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) +7.52%
Jun-28-23 04:30PM	DermTech Announces Restructuring to Prioritize Growth Opportunities and Streamline Operations (Business Wire)
Jun-20-23 05:25AM	If You Own These 3 Growth Stocks, You Might Want to Rethink Your Position (Motley Fool) -5.43%
Jun-14-23 08:00AM	ECRI Completes Evaluation of the Pigmented Lesion Assay (PLA), the Foundational Assay for the DermTech Melanoma Test (DMT) (Business Wire) -5.33%
Jun-07-23 08:00AM	DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire)
Jun-02-23 04:05PM	DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
May-31-23 08:00AM	DermTech Surpasses 200,000 Cumulative Billable Samples for the DermTech Melanoma Test (DMT) (Business Wire)
May-11-23 08:00AM	DermTech Announces Agreements With South Carolina Blues Plan and the United Mine Workers of America Health and Retirement Funds for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) -11.83%
May-10-23 10:40AM	DermTech, Inc. (NASDAQ:DMTK) Analysts Just Slashed This Year's Revenue Estimates By 16% (Simply Wall St.) -5.07%
08:00AM	DermTech Grants New CEO Bret Christensen Inducement Award Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
08:00AM	Loading…
May-09-23 08:00AM	DermTech Appoints Bret Christensen as New President and CEO (Business Wire) +10.84%
May-06-23 08:40AM	DermTech, Inc. (NASDAQ:DMTK) Not Doing Enough For Some Investors As Its Shares Slump 37% (Simply Wall St.)
May-04-23 05:45PM	DermTech, Inc. (DMTK) Reports Q1 Loss, Lags Revenue Estimates (Zacks) +7.51%
04:01PM	DermTech Reports First-Quarter 2023 Financial Results (Business Wire)
May-01-23 04:30PM	New Survey Data Reveals Nearly 75% of Consumers Have Not Had a Full Skin Exam Within the Past 12 Months (Business Wire)
Apr-26-23 08:05AM	DermTech Announces Contract With New York Health Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire)
Apr-13-23 08:05AM	DermTech Announces Release Date for First-quarter 2023 Financial Results (Business Wire)
Apr-11-23 08:05AM	DermTech Announces Contract With North Carolina Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) +18.21%
Apr-05-23 10:00AM	New Survey Finds Millennials and Gen Xers Not Following Safe Sun Habits, Increasing Risk of Nonmelanoma Skin Cancer (Business Wire) -6.17%
Apr-03-23 04:15PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Mar-14-23 04:30PM	DermTech to Present Four New Posters and Demonstrate its Smart Stickers at the 2023 American Academy of Dermatology (AAD) Annual Meeting (Business Wire)
Mar-07-23 08:05AM	DermTech Adds Approximately 1.9 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire)
Mar-06-23 05:52AM	DermTech, Inc. (NASDAQ:DMTK) Q4 2022 Earnings Call Transcript (Insider Monkey) -8.52%
Mar-03-23 08:05AM	DermTech to Present at March Investor Conferences (Business Wire) +17.37%
Mar-02-23 05:15PM	DermTech, Inc. (DMTK) Reports Q4 Loss, Tops Revenue Estimates (Zacks) -7.77%
04:01PM	DermTech Reports Fourth-Quarter and Full-Year 2022 Financial Results; Company Announces CEO Transition Plan (Business Wire)
Feb-12-23 09:53AM	Here's Why We're Watching DermTech's (NASDAQ:DMTK) Cash Burn Situation (Simply Wall St.)
Feb-10-23 08:30AM	DermTech Announces Release Date for Fourth-Quarter 2022 Financial Results (Business Wire) -5.48%
Feb-09-23 08:30AM	DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by the Veterans Health Administration (Business Wire) +17.98%
Jan-27-23 08:30AM	DermTech Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (Business Wire)
Jan-23-23 08:30AM	DermTech Adds Approximately 1.2 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) +23.67%
Jan-18-23 05:55AM	This Under-the-Radar Stock Has Tripled in 2023 -- and Could Have More Room to Run (Motley Fool) -25.47%
Jan-16-23 07:04AM	Institutions profited after DermTech, Inc.'s (NASDAQ:DMTK) market cap rose US$79m last week butindividual investors profited the most (Simply Wall St.)
Jan-10-23 08:30AM	DermTech Announces the Foundational Assay of Its DermTech Melanoma Test (DMT) Is Recommended for Coverage by TRICARE (Business Wire) +47.25%
Jan-05-23 08:30AM	DermTech Adds Approximately 13 Million Covered Lives for the Foundational Assay of Its DermTech Melanoma Test (DMT) (Business Wire) +8.54%
Dec-20-22 05:37AM	DermTech (NASDAQ:DMTK investor one-year losses grow to 89% as the stock sheds US$8.8m this past week (Simply Wall St.)
Dec-16-22 04:05PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Nov-15-22 04:30PM	DermTech and Sonora Quest Laboratories Expand Access to Innovative Melanoma Detection Test (Business Wire)
Nov-09-22 05:48AM	DermTech Third Quarter 2022 Earnings: EPS Beats Expectations, Revenues Lag (Simply Wall St.) +9.84%
Nov-06-22 07:06AM	DermTech, Inc. (NASDAQ:DMTK) Analysts Are Cutting Their Estimates: Here's What You Need To Know (Simply Wall St.)
Nov-03-22 05:55PM	DermTech, Inc. (DMTK) Reports Q3 Loss, Misses Revenue Estimates (Zacks)
04:01PM	DermTech Reports Third-Quarter 2022 Financial Results (Business Wire)
Oct-13-22 04:05PM	DermTech Announces Release Date for Third-Quarter 2022 Financial Results (Business Wire)
Oct-10-22 04:30PM	DermTech Presents on Translational Medicine to Revolutionize Dermatologic Care at the Biomarkers & Precision Medicine USA Congress (Business Wire)
04:05PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire)
Oct-03-22 04:30PM	DermTech Presents on Technological Advances and the Value of Decentralization at Outsourcing in Clinical Trials Southern California (Business Wire)
Sep-16-22 04:30PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) -9.21%
Sep-07-22 10:00AM	Will These Two Stocks Boom or Bust? (Motley Fool) +6.08%
Aug-08-22 05:45PM	DermTech, Inc. (DMTK) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:01PM	DermTech Reports Second-Quarter 2022 Financial Results; Company Updates Full-Year 2022 Outlook (Business Wire)
Aug-02-22 11:03AM	Is DermTech, Inc. (NASDAQ:DMTK) Popular Amongst Insiders? (Simply Wall St.)
Aug-01-22 10:01AM	Earnings Preview: DermTech, Inc. (DMTK) Q2 Earnings Expected to Decline (Zacks)
Jul-28-22 04:05PM	DermTech Appoints Chief Compliance Officer and SVP of Research and Development (Business Wire)
Jul-26-22 04:05PM	DermTech Announces Release Date for Second-Quarter 2022 Financial Results (Business Wire)
Jul-18-22 04:05PM	DermTech Appoints Two New Board Members (Business Wire)
Jul-06-22 04:30PM	DermTech Joins PeDRA Corporate Council, Supporting Efforts to Address Pediatric Skin Diseases (Business Wire)
Jul-03-22 10:45AM	Investors one-year losses grow to 85% as the stock sheds US$29m this past week (Simply Wall St.)
Jun-20-22 05:09AM	Agiliti (AGTI) Stock Jumps 5.5%: Will It Continue to Soar? (Zacks)
Jun-14-22 04:05PM	DermTech to Present on Genomic Innovation in Dermatology at AHIP 2022 (Business Wire)
Jun-07-22 05:00PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +6.71%
Jun-02-22 10:36AM	Will DermTech (NASDAQ:DMTK) Spend Its Cash Wisely? (Simply Wall St.) +8.55%
Jun-01-22 04:05PM	DermTech to Present at the William Blair Growth Stock Conference (Business Wire) -6.63%
May-24-22 04:30PM	DermTech Sponsors The Sun Bus to Bring Free Skin Cancer Screenings to More Than 50 Locations Across the U.S. (Business Wire)
May-18-22 04:30PM	DermTech Presents New Research Differentiating Atopic Dermatitis and Psoriasis at the Society for Investigative Dermatologys Annual Meeting (Business Wire) -8.77%
May-10-22 04:30PM	DermTech Reinforces Longstanding Mission to Help Reduce Melanoma Deaths, Aligning with the Biden Administrations Renewed Cancer Moonshot Program (Business Wire)
May-08-22 08:11PM	Time to Bottom Fish? 3 Strong Buy Stocks That Are Down Around 50% This Year (TipRanks)
May-04-22 04:30PM	DermTech Kicks Off Second Annual #Stickit2Melanoma Campaign, Raising Awareness for Melanoma and the Importance of Skin Exams (Business Wire)
May-03-22 05:15PM	DermTech, Inc. (DMTK) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	DermTech Reports First-Quarter 2022 Financial Results; Company Affirms Full-Year 2022 Outlook (Business Wire)
Apr-28-22 04:30PM	DermTech Announces Publication of New GvHD Clinical Research Conducted in Collaboration with Memorial Sloan Kettering Cancer Center (Business Wire)
Apr-26-22 04:30PM	DermTech Expands Telehealth Application, DermTech Connect, Across 44 States (Business Wire) -8.94%
Apr-25-22 04:30PM	DermTech to Showcase DermTech Stratum, an Expanded Translational Medicine Service Offering, at San Diegos Inaugural Innovation Day Event (Business Wire)
Apr-14-22 04:01PM	DermTech Announces Release Date for First-Quarter 2022 Financial Results (Business Wire) -5.23%
Mar-28-22 04:01PM	DermTech Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (Business Wire) +5.89%
Mar-08-22 09:00AM	DermTech Study, "Cost-Benefit Analysis of the Pigmented Lesion Assay When Introduced into the Visual Assessment / Histopathology Pathway for Lesions Clinically Suspicious for Melanoma," Published in SKIN: The Journal of Cutaneous Medicine (Business Wire)
Mar-01-22 05:15PM	DermTech, Inc. (DMTK) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:01PM	DermTech Reports Fourth Quarter and Full Year 2021 Financial Results (Business Wire)
Feb-24-22 04:01PM	DermTech Management to Present at Upcoming Investor Conferences (Business Wire) +10.38%
Feb-23-22 04:30PM	DermTech Welcomes Adelle Walker as Vice President of Consumer Products (Business Wire) -5.13%
Feb-15-22 04:01PM	DermTech to Announce Fourth Quarter and Full-Year Financial Results (Business Wire) +7.61%

DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Sun Kevin M	Chief Financial Officer	Sep 11	Sale	1.89	436	824	282,925	Sep 12 08:07 PM
Ibarra Claudia	Chief Operating Officer	Sep 11	Sale	1.89	322	609	200,396	Sep 12 08:06 PM
Sun Kevin M	Chief Financial Officer	Sep 08	Sale	1.93	9,180	17,717	283,361	Sep 12 08:07 PM
Ibarra Claudia	Chief Operating Officer	Sep 08	Sale	1.93	7,378	14,240	200,718	Sep 12 08:06 PM
Akhavan Ramin	General Counsel	Sep 08	Sale	1.93	4,531	8,745	142,887	Sep 12 08:04 PM
Sun Kevin M	Chief Financial Officer	Jun 12	Sale	2.85	437	1,245	290,041	Jun 14 08:16 PM
Wood Todd Michael	Chief Commercial Officer	Jun 12	Sale	2.85	350	998	284,757	Jun 14 08:17 PM
Ibarra Claudia	Chief Operating Officer	Jun 12	Sale	2.85	322	918	208,096	Jun 14 08:13 PM
Sun Kevin M	Chief Financial Officer	Jun 08	Sale	2.61	2,828	7,381	290,478	Jun 09 06:47 PM
Ibarra Claudia	Chief Operating Officer	Jun 08	Sale	2.61	2,371	6,188	208,418	Jun 09 06:47 PM
Wood Todd Michael	Chief Commercial Officer	Jun 07	Sale	2.53	4,992	12,630	285,107	Jun 09 06:52 PM
Sun Kevin M	Chief Financial Officer	Jun 07	Sale	2.53	4,988	12,620	293,306	Jun 09 06:47 PM
Ibarra Claudia	Chief Operating Officer	Jun 07	Sale	2.53	3,916	9,907	210,789	Jun 09 06:47 PM
Akhavan Ramin	General Counsel	Jun 07	Sale	2.53	3,776	9,553	147,418	Jun 09 06:46 PM
Dobak John	Chief Executive Officer	Mar 13	Sale	3.26	1,559	5,082	698,693	Mar 13 08:10 PM
Sun Kevin M	Chief Financial Officer	Mar 13	Sale	3.26	514	1,676	298,294	Mar 15 08:02 PM
Wood Todd Michael	Chief Commercial Officer	Mar 13	Sale	3.26	412	1,343	290,099	Mar 15 08:03 PM
Ibarra Claudia	Chief Operating Officer	Mar 13	Sale	3.26	378	1,232	214,705	Mar 15 08:00 PM
Sun Kevin M	Chief Financial Officer	Mar 08	Sale	3.88	3,020	11,718	298,808	Mar 09 08:06 PM
Ibarra Claudia	Chief Operating Officer	Mar 08	Sale	3.88	2,525	9,797	215,083	Mar 09 08:03 PM
Dobak John	Chief Executive Officer	Mar 07	Sale	4.06	23,955	97,257	643,845	Mar 09 08:17 PM
Wood Todd Michael	Chief Commercial Officer	Mar 07	Sale	4.06	8,713	35,375	205,397	Mar 09 08:07 PM
Sun Kevin M	Chief Financial Officer	Mar 07	Sale	4.06	8,687	35,269	216,714	Mar 09 08:06 PM
Ibarra Claudia	Chief Operating Officer	Mar 07	Sale	4.06	7,091	28,789	150,731	Mar 09 08:03 PM
Akhavan Ramin	General Counsel	Mar 07	Sale	4.06	6,751	27,409	84,317	Mar 09 08:01 PM
Wood Todd Michael	Chief Commercial Officer	Dec 12	Sale	2.22	356	790	214,110	Dec 14 08:00 PM
Ibarra Claudia	Chief Operating Officer	Dec 12	Sale	2.22	328	728	157,822	Dec 14 08:14 PM
Ibarra Claudia	Chief Operating Officer	Dec 08	Sale	2.32	2,496	5,791	158,150	Dec 08 08:00 PM
Wood Todd Michael	Chief Commercial Officer	Dec 08	Sale	2.32	448	1,039	214,466	Dec 08 08:01 PM
Wood Todd Michael	Chief Commercial Officer	Dec 06	Sale	2.44	185	451	214,914	Dec 08 08:01 PM
Ibarra Claudia	Chief Operating Officer	Dec 06	Sale	2.44	137	334	160,646	Dec 08 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DMTK

DermTech Inc

Upgrade your FINVIZ experience